Brenda O’Connell
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 10%
- Cell Biology top 10%
- Immunology
- Co-authors
- J. Wade HarperJohn M. SedivySteven P. GygiMathew E. SowaStephen J. ElledgeAgata SmogorzewskaJennifer M. SvendsenMaria K. Mateyak
- Topics
- Cancer Immunotherapy and Biomarkers (8 papers)Ubiquitin and proteasome pathways (5 papers)Advanced Breast Cancer Therapies (3 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Brenda O’Connell
21 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 1.4k
- Oncology 480
- Cancer Research 292
- Cell Biology 182
- Immunology 168
Countries citing papers authored by Brenda O’Connell
This map shows the geographic impact of Brenda O’Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda O’Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda O’Connell more than expected).
Fields of papers citing papers by Brenda O’Connell
This network shows the impact of papers produced by Brenda O’Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda O’Connell. The network helps show where Brenda O’Connell may publish in the future.
Co-authorship network of co-authors of Brenda O’Connell
This figure shows the co-authorship network connecting the top 25 collaborators of Brenda O’Connell. A scholar is included among the top collaborators of Brenda O’Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda O’Connell. Brenda O’Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 32 | |
| 3 | 48 | |
| 4 | 12 | |
| 5 | 14 | |
| 6 | 5 | |
| 7 | 10 | |
| 8 | 9 | |
| 9 | 51 | |
| 10 | 14 | |
| 11 | 75 | |
| 12 | 90 | |
| 13 | 358 | |
| 14 | 12 | |
| 15 | 45 | |
| 16 | 41 | |
| 17 | 23 | |
| 18 | 185 | |
| 19 | 158 | |
| 20 | 400 |
About Brenda O’Connell
Brenda O’Connell is a scholar working on Oncology, Molecular Biology and Cell Biology, having authored 21 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Ubiquitin and proteasome pathways (5 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Cancer Research (292 citations) and Oncology (480 citations). Brenda O’Connell has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include J. Wade Harper, John M. Sedivy, Steven P. Gygi, Mathew E. Sowa, Stephen J. Elledge, Agata Smogorzewska, Jennifer M. Svendsen, Maria K. Mateyak, Franz Kohlhuber and Heiko Hermeking. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.